|
|
| Interim CEO - Mark McDonough |
 |
Mark McDonough serves as Interim CEO of Cyrex Labs as of May 2024. Prior to this, he served in several private and public company CEO roles to include PierianDx and CombiMatrix, a publicly held molecular diagnostics company performing DNA-based testing services for reproductive health, oncology, and developmental disorders.
As CEO of CombiMatrix, from 2013-2017, Mark led a dramatic turnaround of a struggling company with a precise focus on high margin growth coupled with disciplined cost reduction. CombiMatrix revenue grew 300% over his tenure and achieved profitability. At PierianDx, he led 40% revenue growth in back-to-back years leading to significant Private Equity interest. Mark has also held executive and management positions with US LABS (acquired by LabCorp) and Ventana Medical Systems (acquired by Roche). Mark is the Founder and CEO of McDonough Leadership Advisors, a private consulting firm specializing in company, culture, and commercial growth expertise. |
| Laboratory Director - Sadi, Koksoy, DVM, PhD, HCLD (ABB) |
Dr. Koksoy received his MSc and PhD degrees from the Ohio State University, and his DVM degree, from Ankara University, Turkey. He has a High Complexity Lab Director (HCLD) certificate from ABB (American Board of Bioanalysis) in Diagnostic Immunology. Before joining Cyrex Laboratories in June 2023, Dr. Koksoy worked as a Professor of Medical Microbiology and Immunology, and the Founding Director of the Clinical and Research Immunology Laboratory and Flow Cytometry Core at Akdeniz University, School of Medicine, Turkey for over 14 years. There he developed and validated various state-of-the-art flow cytometric and immunological tests and procedures that meet national and international regulatory standards for the immunologic assessment of transplant patients, diagnosing immunodeficiencies, autoimmune diseases, hematologic malignancies, and certain infections. He also served as the Associate Director of the Histocompatibility and Immunogenetics laboratory, which is a part of one of the largest transplantation centers in Europe.
Dr. Koksoy taught classes in the fields of Microbiology and Immunology to Medical and Graduate Students and trained many professionals. He has authored/co-authored more than 50 SCI-indexed manuscripts in scientific journals.
|
 |
| Mark R. Engelman- Director of Clinical Consulting- M.D, FSCM, FAARM, ABAARM |
 |
Dr. Engelman received his BS undergraduate degree from Ohio State University. He received an M.D, degree from Ohio State College of Medicine. He was a resident in Internal Medicine at St. Joseph’s Hospital and Medical Center, Phoenix, Arizona. Dr. Engelman was an Emergency Department staff Physician at St. Joseph’s for 23 years and served as Emergency Department Director for 22 years. He was Board Certified in Emergency Medicine. Dr. Engelman became fascinated about Integrative Functional Medicine. He has earned a Fellowship in Stem Cell Medicine Certification and Advanced Fellowship in Integrative Functional Medicine. He is the Founder and Director of Engelman Health Institute in Phoenix and has utilized Cyrex Labs in his practice. |
|
CYREX LABORATORIES'
ADVISORS
|
|
| Chief Scientific Advisor - Aristo Vojdani, Ph.D., M.Sc., C.L.S. |
| Dr. Aristo Vojdani obtained his Ph.D. in the field of microbiology and clinical immunology with postdoctoral studies in tumor immunology at UCLA. Vojdani’s ongoing research, spanning a 40-year career, focuses on the role of environmental factors, such as toxic chemicals, infections and dietary proteins and peptides in complex diseases. An owner of 15 U.S. patents for laboratory assessments, he has published 120 peer-reviewed articles in scientific journals. Dr. Vojdani is CEO and technical director of Immunosciences Lab., Inc. in Los Angeles, CA, a member of the editorial board of four scientific journals, and a guest editor of six journals. |
 |
|
|